Mimedx (MDXG) Amortization - Intangibles (2012 - 2026)
Mimedx recorded quarterly Amortization - Intangibles of $301000.0 in Q1 2026, up 133.33% quarter-over-quarter from $129000.0 in Q4 2025, and up 204.04% year-over-year from $99000.0 in Q1 2025.
Mimedx's Amortization - Intangibles history runs 15 years deep, the most recent figure standing at $301000.0 for Q1 2026.
- In Q1 2026, Amortization - Intangibles rose 204.04% year-over-year to $301000.0; the TTM figure through Mar 2026 stood at $642000.0 (down 4.75% YoY), while the FY2025 annual figure was $439000.0, down 42.61% from the prior year.
- Amortization - Intangibles came in at $301000.0 for Q1 2026 at Mimedx, up from $129000.0 in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $301000.0 in Q1 2026 to a low of $99000.0 in Q1 2025.
- A 5-year average of $174705.9 and a median of $189000.0 in 2024 frame the typical range for Amortization - Intangibles.
- Across the five-year window, Amortization - Intangibles slumped 47.62% in 2025 and surged 204.04% in 2026, its largest moves.
- Mimedx's Amortization - Intangibles stood at $182000.0 in 2022, then advanced by 5.49% to $192000.0 in 2023, then rose by 0.52% to $193000.0 in 2024, then plunged by 33.16% to $129000.0 in 2025, then surged by 133.33% to $301000.0 in 2026.
- According to Business Quant data, Amortization - Intangibles over the past three periods registered $301000.0, $129000.0, and $112000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 301,000.00 |
| Dec 31, 2025 | 129,000.00 |
| Sep 30, 2025 | 112,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 99,000.00 |
| Dec 31, 2024 | 193,000.00 |
| Sep 30, 2024 | 192,000.00 |
| Jun 30, 2024 | 190,000.00 |
| Mar 31, 2024 | 189,000.00 |
| Dec 31, 2023 | 192,000.00 |
| Sep 30, 2023 | 190,000.00 |
| Jun 30, 2023 | 191,000.00 |
| Mar 31, 2023 | 190,000.00 |
| Dec 31, 2022 | 182,000.00 |
| Sep 30, 2022 | 175,000.00 |
| Jun 30, 2022 | 173,000.00 |
| Mar 31, 2022 | 172,000.00 |
| Dec 31, 2021 | 173,000.00 |
| Sep 30, 2021 | 193,000.00 |
| Jun 30, 2021 | 215,000.00 |
| Mar 31, 2021 | 239,000.00 |
| Dec 31, 2020 | 255,000.00 |
| Sep 30, 2020 | 276,000.00 |
| Jun 30, 2020 | 271,000.00 |
| Mar 31, 2020 | 271,000.00 |
| Dec 31, 2019 | 270,000.00 |
| Sep 30, 2019 | 269,000.00 |
| Jun 30, 2019 | 267,000.00 |
| Mar 31, 2019 | 200,000.00 |
| Dec 31, 2018 | 234,000.00 |
| Sep 30, 2018 | 260,000.00 |
| Jun 30, 2018 | 200,000.00 |
| Mar 31, 2018 | 252,000.00 |
| Dec 31, 2017 | 227,000.00 |
| Sep 30, 2017 | 418,000.00 |
| Jun 30, 2017 | 507,000.00 |
| Mar 31, 2017 | 526,000.00 |
| Dec 31, 2016 | 211,000.00 |
| Sep 30, 2016 | 631,000.00 |
| Jun 30, 2016 | 447,000.00 |
| Mar 31, 2016 | 810,000.00 |
| Dec 31, 2015 | 234,000.00 |
| Sep 30, 2015 | 234,000.00 |
| Jun 30, 2015 | 233,000.00 |
| Mar 31, 2015 | 233,000.00 |
| Dec 31, 2014 | 233,000.00 |
| Sep 30, 2014 | 232,000.00 |
| Jun 30, 2014 | 232,000.00 |
| Mar 31, 2014 | 231,000.00 |
| Dec 31, 2013 | 264,191.00 |
| Sep 30, 2013 | 259,575.00 |
| Jun 30, 2013 | 267,638.00 |
| Mar 31, 2013 | 262,596.00 |
| Dec 31, 2012 | 262,354.00 |
| Sep 30, 2012 | 449,692.00 |
| Jun 30, 2012 | 333,977.00 |
| Mar 31, 2012 | 333,977.00 |